Skip to main content
Caplight Logo









Curacel

Curacel

Private
LagosFinTechhttps://curacel.co

Last Round

Seed

Feb 14, 2023

Total Funding Raised

$3.98M

Company Overview

Curacel is an insurtech company that provides an AI-powered infrastructure platform to automate insurance processes, including claims, fraud detection, and embedded insurance products for emerging markets.

Sector

FinTech

Verticals

InsurTech, API Management, Workflow Automation, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Marketplace Commission, Services & Consulting

AI Layer

Application

Keywords

insurtechembedded insuranceclaims processinginsurance infrastructureinsurance techclaims automationinsurance-as-a-serviceinsurance APIfraud detectionhealth maintenance organizationHMOclaims managementclaims-as-a-serviceclaims adjudicationvertical SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Curacel Comparables

Compare Curacel with similar companies based on industry and business-model similarity.

Curacel comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Octamile
91%
Lami
88%
Unyte Africa
86%

Curacel Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 14, 2023
AcceleratorMar 10, 2022
Pre SeedMar 30, 2021
AcceleratorJul 12, 2019
GrantOct 3, 2016

Key People

Founding team and executive leadership

Henry Mascot

Founder CEO

Founding Team

John Dada

Chief Technology Officer

Executive Team

Curacel Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 14, 2023

    $3M round with participation from Elefund and Olive Tree Capital.

  • Mar 10, 2022

    $500K round led by Y Combinator

Recent news

Latest coverage and updates

  • receives_financingAug 5, 2026

    Curacel Inc., a Delaware-based insurance infrastructure provider, raises $3M in a Seed funding round in Delaware on Feb 14th '23.

Curacel Filings

Explore SEC and related filing metadata, where available.

Curacel filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Curacel's valuation, stock price, and market status.

Is Curacel a public or private company?

Curacel is a private company.

What is the current stock price of Curacel?

Curacel is a private company, so its shares have no public market price. Caplight tracks Curacel's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Curacel worth (valuation)?

Valuation information for Curacel is not publicly available.

Can I buy Curacel stock?

Curacel shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Curacel's last funding round?

Curacel's most recent funding round was Seed on February 14, 2023.

Who are the main investors in Curacel?

Key investors in Curacel include Startupbootcamp AfriTech, Y Combinator, Consonance Investment Managers, Atlantica Ventures.

Will Curacel IPO soon?

No public IPO plans have been announced for Curacel.

How can I track Curacel secondary market activity?

Caplight tracks bids, offers, and trades in Curacel's shares on secondary markets.

Firmographic Details

HeadquartersLagos
Employee Range46
Year Founded2019
Last FundingFeb 14, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?